- Home
- SWZ vs FBIO Comparison
SWZ vs FBIO Comparison
Compare SWZ & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SWZ | FBIO |
|---|---|---|
| Founded | 1986 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.5M | 80.4M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | SWZ | FBIO |
|---|---|---|
| Price | $5.85 | $1.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 33.7K | ★ 254.8K |
| Earning Date | 01-01-0001 | 11-13-2026 |
| Dividend Yield | ★ 6.59% | N/A |
| EPS Growth | N/A | ★ 97.40 |
| EPS | N/A | ★ 2.86 |
| Revenue | N/A | ★ $63,262,000.00 |
| Revenue This Year | N/A | $24.55 |
| Revenue Next Year | N/A | $43.73 |
| P/E Ratio | ★ N/A | $0.70 |
| Revenue Growth | N/A | ★ 9.69 |
| 52 Week Low | $5.68 | $1.83 |
| 52 Week High | $6.31 | $4.53 |
Technical Indicators
Market Signals| Indicator | SWZ | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 52.48 | 34.67 |
| Support Level | $5.68 | N/A |
| Resistance Level | $6.00 | $2.17 |
| Average True Range (ATR) | 0.04 | 0.08 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 80.00 | 26.47 |
Price Performance
Historical ComparisonAbout SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. It actively manages investment solutions spanning public and private markets, wealth management, and Solutions.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.